Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.
about
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug usersPolice and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facilityEffects of police confiscation of illicit drugs and syringes among injection drug users in VancouverNorepinephrine and stimulant addictionTrends in production, trafficking, and consumption of methamphetamine and cocaine in MexicoThe cost-effectiveness of Vancouver's supervised injection facilitySummary of findings from the evaluation of a pilot medically supervised safer injecting facilityThe impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine usersNeedle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of researchFactors associated with spontaneous clearance of hepatitis C virus among illicit drug usersAddiction treatment and stable housing among a cohort of injection drug usersPersonalized risk assessment of drug-related harm is associated with health outcomesOutlier populations: individual and social network correlates of solvent-using injection drug usersHIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.Public health and international drug policy.Risk Factors Associated with Unsafe Injection Practices at the First Injection Episode among Intravenous Drug Users in France: Results from PrimInject, an Internet Survey.Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART.Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort studyElevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis.Injection drug use among street-involved youth in a Canadian setting.Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.Strategies to avoid opiate withdrawal: implications for HCV and HIV risksAt-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City.Pathways to HIV risk and vulnerability among lesbian, gay, bisexual, and transgendered methamphetamine users: a multi-cohort gender-based analysis.Assisted injection in outdoor venues: an observational study of risks and implications for service delivery and harm reduction programming.Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal studyThe impact of engagement in street-based income generation activities on stimulant drug use cessation among people who inject drugsAn external evaluation of a peer-run outreach-based syringe exchange in Vancouver, CanadaSurvival sex work involvement among street-involved youth who use drugs in a Canadian setting.The impact of childhood emotional abuse on violence among people who inject drugsHarm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting.The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort studyExamining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control womenTHE FIRST INJECTION EVENT: DIFFERENCES AMONG HEROIN, METHAMPHETAMINE, COCAINE, AND KETAMINE INITIATES.Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study.Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy.Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users
P2860
Q24561498-7EB437B1-4054-4A05-A1C7-8F43FA004FF9Q24649575-E06931A4-849B-4131-A06B-CAC1699B19F4Q24654664-54140D29-6FA1-4E71-A863-300C4EF6C0B8Q24656833-EFC1673D-869F-4902-A8BF-E9EAB1811118Q24657648-76A9BFB8-8DE2-4550-8BCE-5DA2F887F76CQ24657903-4FBBC428-322D-4F84-A012-E24164D16C0AQ24673390-92FDFB07-679B-4AAC-9140-52234F9AAD3EQ24811537-D2EBEE7E-0DBD-49B3-B5C9-D588E7CD3774Q25257807-70BDD819-958F-4749-B874-60E3B15D41C4Q27024650-9B4F8D56-9E39-4FE0-90A6-C0C35358A0CAQ27488233-A0C205E0-2BE4-4971-B56E-5842E8471D9BQ28474879-C06849B3-F733-4800-8F13-5B8C753E3203Q28534851-F2A718CB-A590-4A13-9704-48E9541A6C1AQ28539716-04375EA3-A0D2-43F5-BE8A-6416533DE816Q30226766-CA31BE32-D8B2-4952-9F7D-255B0114B36BQ30377895-13350E6A-BF30-4F05-8129-B761704DE0E6Q30668946-E9F44AE8-0119-465A-B97F-767FD5BB936EQ33244605-2F0BC366-955E-42EA-90FB-F16FB9782506Q33391591-CE90969F-52D6-4983-BD98-B4B76F78BA93Q33453958-D413FF90-AA32-47A3-B49B-AE40F4CDAEBCQ33459548-73D7DEF6-9E75-426F-BB2A-5216EF483AE2Q33488345-53C50164-1CEE-4E9B-ADC9-EBD06ADE120FQ33507211-DCC776EB-D105-4118-8137-F75A6796B3ADQ33705656-2F9867EE-E7A4-4D77-AFFE-1F1E48593C18Q33788467-D1A7E101-5504-4B9A-9335-DA7BC41F08CBQ33797471-2900C103-3A92-4DFE-9B43-801367E726A3Q33833339-549E6A64-9D25-4E48-A5EF-6672AD853481Q33874564-A98574A1-264D-498B-B203-415AB7363C35Q33959593-9FB3E785-DF53-4825-B5C5-BA2E8C83B236Q34076642-A1F98F13-CD23-4F2F-B1E3-0DCDB13A3A60Q34207388-F64683BE-84B3-4190-B07B-6C14DC50C13EQ34251466-6FE21CFC-580E-4233-A352-D7F9749536AAQ34373050-E50581DC-99FE-4FB9-85CF-6F2620456108Q34521683-9EBF03F6-A6A7-4A0C-8A36-E9115FDA4FE3Q34582040-81BD7F32-9B58-4A13-9385-0F62E634E444Q34614145-3C06D275-2D3A-4162-9AEE-49AD15FE5246Q34687144-22DD7B5E-06C5-4789-9A8A-C7E33F6828F7Q34690989-F603C2AD-D25E-4FC0-9656-E04C91F6396FQ34735099-360A3EAC-EA6F-4EFC-B495-153B07D44103Q34754918-1F5CE7BC-7353-4983-97D7-02FBAA87C408
P2860
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@en
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@nl
type
label
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@en
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@nl
prefLabel
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@en
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@nl
P2093
P1433
P1476
Intensive injection cocaine us ...... the Vancouver HIV-1 epidemic.
@en
P2093
Mark W Tyndall
Michael V O'Shaughnessy
Patricia Spittal
Sue Currie
P304
P356
10.1097/00002030-200304110-00014
P407
P577
2003-04-01T00:00:00Z